Development of novel orally available anti-inflammatory therapeutics

• Unité de recherche: INNOSUISSE
• Numéro de projet: 27862.1 PFLS-LS
• Titre du projet anglais: Development of novel orally available anti-inflammatory therapeutics

Description succincte (Allemand)

Development of novel orally available anti-inflammatory therapeutics

Description succincte (Anglais)

Development of novel orally available anti-inflammatory therapeutics

Résumé des résultats (Abstract) (Allemand)

To further develop identified A2AR PAM hits towards first-in-class selective orally available small molecule as novel anti-inflammatory therapy that will preserve the natural spatio-temporal control over A2AR engagement, therefore avoiding side-effects relating to systemic triggering of A2AR.

Résumé des résultats (Abstract) (Anglais)